ArriVent BioPharma
AVBP
AVBP
83 hedge funds and large institutions have $539M invested in ArriVent BioPharma in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
29% less capital invested
Capital invested by funds: $757M → $539M (-$218M)
Holders
83
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$7.81M | |
| 2 | +$6.5M | |
| 3 | +$2.39M | |
| 4 |
Millennium Management
New York
|
+$1.95M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$1.69M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$2.41M | |
| 3 | -$857K | |
| 4 |
Morgan Stanley
New York
|
-$493K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$414K |